reiterateEXPEfinnhub
UBS Reiterates Neutral Rating on Expedia Group, Inc. (EXPE)
UBS reiterated its Neutral rating on Expedia Group, Inc. (NASDAQ:EXPE) on November 03, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
UBS reiterated its Neutral rating on Expedia Group, Inc. (NASDAQ:EXPE) on November 03, 2026.
Read moreBTIG reiterated its Buy rating on Tactile Systems Technology, Inc. (NASDAQ:TCMD) on November 03, 2026.
Read moreFreedom Broker analysts initiated coverage on MNTN Inc. (NYSE:MNTN) with a rating of Buy on November 03, 2026.
Read moreCitigroup analysts upgraded Afya Limited (NASDAQ:AFYA) from Neutral to Buy on November 03, 2026.
Read moreRosenblatt reiterated its Buy rating on Harmonic Inc. (NASDAQ:HLIT) on November 03, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Harmonic Inc. (NASDAQ:HLIT) on November 03, 2026.
Read moreNeedham reiterated its Buy rating on nLIGHT, Inc. (NASDAQ:LASR) on November 03, 2026.
Read moreBarclays reiterated its Overweight rating on FIGS, Inc. (NYSE:FIGS) on November 03, 2026.
Read moreKeefe, Bruyette & Woods reiterated its Outperform rating on Walker & Dunlop, Inc. (NYSE:WD) on November 03, 2026.
Read moreNeedham reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Read moreCanaccord Genuity reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Read moreStifel reiterated its Buy rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Read moreEvercore ISI Group reiterated its Outperform rating on Hinge Health, Inc. (NYSE:HNGE) on November 03, 2026.
Read moreBarclays reiterated its Equal-Weight rating on Eastern Bankshares, Inc. (NASDAQ:EBC) on November 03, 2026.
Read moreBarclays reiterated its Overweight rating on Associated Banc-Corp (NYSE:ASB) on November 03, 2026.
Read moreNeedham reiterated its Buy rating on CRISPR Therapeutics AG (NASDAQ:CRSP) on November 03, 2026.
Read moreCantor Fitzgerald reiterated its Overweight rating on Cipher Mining Inc. (NASDAQ:CIFR) on November 03, 2026.
Read moreRosenblatt reiterated its Buy rating on Cipher Mining Inc. (NASDAQ:CIFR) on November 03, 2026.
Read moreBaird reiterated its Outperform rating on Axsome Therapeutics, Inc. (NASDAQ:AXSM) on November 03, 2026.
Read moreGuggenheim reiterated its Buy rating on Axsome Therapeutics, Inc. (NASDAQ:AXSM) on November 03, 2026.
Read more